Virus treatment questioned after gene therapy death.
Lehrman
S
S
D000256:Adenoviridae / Q000235:genetics*; D000328:Adult; D026683:Advisory Committees; D017321:Clinical Trials, Phase I as Topic; D017809:Fatal Outcome; D035082:Federal Government; D005334:Fever / Q000209:etiology; D015316:Genetic Therapy / Q000009:adverse effects*; D005822:Genetic Vectors / Q000009:adverse effects* / Q000235:genetics; D033161:Government Regulation; D006801:Humans; D008297:Male; D009954:Ornithine Carbamoyltransferase / Q000235:genetics; D020163:Ornithine Carbamoyltransferase Deficiency Disease; D035842:Research Subjects; D018570:Risk Assessment; D013927:Thrombosis / Q000209:etiology
D009954:Ornithine Carbamoyltransferase